Bausch + Lomb Files for Public Offering to Meet $700M Financial Obligation

Bausch + Lomb, leading ophthalmology company, is planning for an initial public offering of stock and intends to use the proceeds to repay a $700 million loan, according to an Optics report.

Advertisement

The loan transaction, completed in March, was used to fund a dividend made payable to its stock holders.

Bausch + Lomb is currently $3.3 billion in debt.

More Articles on Ophthalmology:
Dr. Gholma Peyman Joins Insite Vision
5 Recent Ophthalmology-Driven Facility Openings & Expansions
Dr. Balamurali Ambati Leads Study of Nanoparticles as Maculr Degeneration Treatment

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.